This list is an analysis based on recent market events. It's not an investment recommendation.
Cleo Diagnostics Ltd, a biotechnology company, engages in the development and patent of a blood test for the detection of ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia.
FAQs
What is Cleo Diagnostics stock price today?▼
The current price of COV.AU is A$0.28 AUD — it has decreased by -6.78% in the past 24 hours. Watch Cleo Diagnostics stock price performance more closely on the chart.
What is Cleo Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Cleo Diagnostics stocks are traded under the ticker COV.AU.
Is Cleo Diagnostics stock price growing?▼
COV.AU stock has fallen by -6.78% compared to the previous week, the month change is a -20.29% fall, over the last year Cleo Diagnostics has showed a -27.63% decrease.
What is Cleo Diagnostics market cap?▼
Today Cleo Diagnostics has the market capitalization of 37.71M
What is Cleo Diagnostics revenue for the last year?▼
Cleo Diagnostics revenue for the last year amounts to 0 AUD.
What is Cleo Diagnostics net income for the last year?▼
COV.AU net income for the last year is -5.94M AUD.
In which sector is Cleo Diagnostics located?▼
Cleo Diagnostics operates in the Health & Wellness sector.
When did Cleo Diagnostics complete a stock split?▼
Cleo Diagnostics has not had any recent stock splits.
Where is Cleo Diagnostics headquartered?▼
Cleo Diagnostics is headquartered in Melbourne, Australia.